Market Place
Reply
1) IND/NDA/ANDA/USDMF- Status
2) GDUFA- Status
Comments :
chirag@rusanpharma.com
We are a technology driven Pharmaceutical Company managed by a team of professional technocrats. We specialize in the area of critical pain management, substitution treatment, opioid de-addiction, psychiatric drugs, anti- tuberculosis, and anti-infectives.
We manufacture both finished formulations and API’s (Active Pharma Ingredients).
We are manufacturers of both... Naloxone HCl API as well as finished formulations. We can present the the quote once you specify the required grade,dosage form, quantity, location where it is to be supplied,
AAmbrosi@Noramco.com
For more than a decade Noramco has consistently delivered large volumes of Nal-family compounds (Naltrexone and Naloxone) and Buprenorphine HCI to the pharmaceutical industry. Noramco has made a long-term commitment to antagonist APIs, providing both the technologies and expertise pharmaceutical companies require to produce and commercialize addiction treatment and abuse prevention products (ATAP).
Noramco would like to fulfill your API requirements. Noramco will support and supply a CoA.
Please contact via email or phone regarding setting up a time to discuss next steps.
Best Regards
Anthony Ambrosini
VP Business Development
Noramco
215-350-9795
